| 26th November 2015
We are pleased to announce that Blue Latitude Health has won a PMEA 2015 award for our work with Eli Lilly and Company on the Lilly Medical Information Cascade. The project was shortlisted in two categories, and it won the Innovation award. The PMEA awards were presented at a black tie dinner at the Lancaster London Hotel last night. The awards recognise and commend excellence, best practice, and innovation in local, European, and international healthcare markets. The full list of winners can be found here.
Fred Bassett, Co-Founder and Head of Strategy had this to say about our win,
Lilly Medical Cascade is a ground breaking new way for HCPs to quickly, easily and securely access medical product information – both on and off label. Pioneered by us with Lilly, Medical Cascade is set to become the de facto standard for delivering verified medical information and is being rolled out throughout the industry, across brands and around the world. By cleverly utilising Search Engine Optimisation in a new way, we were able to create a secure online service that is compliant, and yet still provides HCPs with answers to their medical product queries in one step.
At a stroke, we eliminated the laborious, time-consuming and costly standard process which could involve call centres, medical advisers, 15-page letters, and a lot of waiting. Lilly Medical Cascade has provided a blueprint for the future of healthcare communication. HCPs can get the information they need reliably and efficiently, in an instant, while pharmaceutical manufacturers can save millions by dealing with queries online.
Thank you and well done to the team behind the Lilly Medical Cascade for all their hard work!
PMLive Digital Print edition: http://digitaleditions.pmlive.com/launch.aspx?pbid=b639752d-420a-4e75-bfc3-9229be2c9c31
| 19th March 2018
Senior Associate Consultant Leah Carlisle gives the inside scoop on what it's like to work at the Blue Latitude Health office in New York.
| 16th March 2018
Precision medicine is set to transform healthcare, however, incorporating these therapies into clinical practice is difficult for both industry and academia. On 14 March 2018, Senior Consultant DavidCooney spoke to top industry players about some of the challenges and opportunities for those working in this innovative field.